Early detection of Parkinson’s disease can vastly improve outcomes. Prof. Tiago Outiero (University Medical Center Goettingen, Goettingen, Germany) discussed with touchNEUROLOGY his research combining basic science to use biological markers and clinical signs to diagnose Parkinson’s disease.
- Why is early detection of Parkinson’s disease essential, and what are the current challenges in achieving this? (00:15)
- Tell us about your approach, which combines aspects of basic science to use biological markers alongside clinical signs to help diagnose Parkinson’s disease. (01:10)
- What have you learned from this approach as applied in other areas of neurological disease? (02:37)
- How do you think these principles should be incorporated into routine practice to help diagnose disease sooner? (03:48)
The session entitled ‘Biological vs Clinical Diagnosis of Parkinson’s disease’ took place at the European Academy of Neurology Congress 2022, 25–28 June 2022.
Disclosure: Tiago Outiero has nothing to disclose in relation to this video interview.
Support: Interview and filming supported by Touch Medical Media. Interview conducted by Lisa Glass.
Filmed as a highlight of EAN 2022.
Share this Video
Related Videos In Parkinson's Disease
Angelo Antonini, EAN 2022: New therapies and optimal treatment approaches for Parkinson’s disease
Data emerging from upcoming clinical trials assessing the treatment efficacy in people with clinically established Parkinson’s disease will shed light on optimal treatment approaches. In this interview with touchNEUROLOGY, Prof. Angelo Antonini (IRCCS San Camillo, Venice, and University of Padova, Italy) gives his thoughts on these and discusses how new efficacious therapies for Parkinson’s disease […]
Angelo Antonini, EAN 2022: Update on disease-modifying treatments in Parkinson’s disease
Slowing down the progression of Parkinson’s disease is key to improving outcomes. In this interview with touchNEUROLOGY, Prof. Angelo Antonini (IRCCS San Camillo, Venice, and University of Padova, Italy) presents the core concept of the Movement Disorders Society Task Force on the biological definition of Parkinson’s disease and treatment objectives, and shares his thoughts on […]
Heinz Reichmann, EAN 2022: Highlights in Parkinson’s disease
In an interview with touchNEUROLOGY, Prof. Heinz Reichmann (University of Dresden Medical School, Germany) gave us his insight into his highlights in Parkinson’s disease, the interventions currently under investigation and how he sees management strategies for Parkinson’s disease evolving in the coming years. Questions: What are your highlights from the Parkinson’s disease scientific sessions at […]
Journal articles and more to your inbox
Get the latest clinical insights from touchNEUROLOGYSign me up!